CT-011, a monoclonal PD-1 blocking antibody, enhances natural killer cell activation and cytotoxicity against multiple myeloma

被引：0
|
作者：
Benson, Don
Chandler, Jason
Mishra, Anjali
Baiocchi, Robert
Yu, Jianhua
Liu, Tom
Lozanski, Gerard
Porcu, Pierluigi
Devine, Steven
Rotem-Yehudar, Rinat
Caligiuri, Michael
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Curetech, Yavne, Israel
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5655
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
    Benson, Don M., Jr.
    Bakan, Courtney E.
    Mishra, Anjali
    Hofmeister, Craig C.
    Efebera, Yvonne
    Becknell, Brian
    Baiocchi, Robert A.
    Zhang, Jianying
    Yu, Jianhua
    Smith, Megan K.
    Greenfield, Carli N.
    Porcu, Pierluigi
    Devine, Steven M.
    Rotem-Yehudar, Rinat
    Lozanski, Gerard
    Byrd, John C.
    Caligiuri, Michael A.
    BLOOD, 2010, 116 (13) : 2286 - 2294
  • [2] CT-011, ANTI PD-1 ANTIBODY, ENHANCES EX-VIVO T CELL RESPONSES TO AUTOLOGOUS DENDRITIC/MYELOMA FUSION VACCINE DEVELOPED FOR THE TREATMENT OF MULTIPLE MYELOMA
    Rosenblatt, J.
    Glotzbecker, B.
    Mills, H.
    Keefe, W.
    Wellenstein, K.
    Vasir, B.
    Wu, Z.
    Zarwan, C.
    Schickler, M.
    Rotem-Yehudar, R.
    Kufe, D.
    Avigan, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S237 - S237
  • [3] PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
    Rosenblatt, Jacalyn
    Glotzbecker, Brett
    Mills, Heidi
    Vasir, Baldev
    Tzachanis, Dimitrios
    Levine, James D.
    Joyce, Robin M.
    Wellenstein, Kerry
    Keefe, Whitney
    Schickler, Michael
    Rotem-Yehudar, Rinat
    Kufe, Donald
    Avigan, David
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (05) : 409 - 418
  • [4] Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results
    Benson, Don
    Hofmeister, Craig C.
    Padmanabhan, Swaminathan
    Abonour, Rafat
    Suvannasankha, Attaya
    Mita, Alain
    Squiban, Patrick
    Smith, Megan K.
    Bakan, Courtney E.
    Marzetto, Marc
    Andre, Pascale
    Tollier, Jerome
    Caligiuri, Michael A.
    Farag, Sherif
    BLOOD, 2009, 114 (22) : 1125 - 1125
  • [5] CT-011, Anti-PD-1 Antibody, Enhances Ex-Vivo T Cell Responses to Autologous Dendritic/Myeloma Fusion Vaccine Developed for the Treatment of Multiple Myeloma
    Rosenblatt, Jacalyn
    Glotzbecker, Brett
    Mills, Heidi
    Keefe, Whitney
    Wellenstein, Kerry
    Vasir, Baldev
    Wu, Zekui
    Zarwan, Corrine
    Schickler, Michael
    Rotem-Yehudar, Rinat
    Kufe, Donald
    Avigan, David
    BLOOD, 2009, 114 (22) : 322 - 323
  • [6] CT-011, a humanized monoclonal antibody, interacts with the PD-1 receptor and modulates survival and trafficking signals in effector/memory T lymphocytes
    Rotem-Yehudar, Rinat
    Rodionov, Galina
    Landes, Shimon
    CANCER RESEARCH, 2009, 69
  • [7] In Vitro and In Vivo Effects of CT-011, a Humanized Anti-PD-1 Monoclonal Antibody, in Combination with Rituximab against Human B-Cell Lymphomas
    Chu, Fuliang
    Foglietta, Myriam
    Qin, Hong
    Sharma, Rakesh
    Yi, Qing
    Rodionov, Galina
    Rotem-Yehudar, Rinat
    Neelapu, Sattva
    BLOOD, 2009, 114 (22) : 302 - 302
  • [8] Novel monoclonal antibody that enhances natural killer (NK) cell cytotoxicity against multiple myeloma (MM): Preclinical data and interim phase I clinical trial results
    Benson, D. M., Jr.
    Romagne, F.
    Squiban, P.
    Wagtmann, N.
    Farag, S.
    Mita, A.
    Hofmeister, C.
    Smith, M.
    Bakan, C.
    Caligiuri, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
    Berger, Raanan
    Rotem-Yehudar, Rinat
    Slama, Gideon
    Landes, Shimon
    Kneller, Abraham
    Leiba, Merav
    Koren-Michowitz, Maya
    Shimoni, Avichai
    Nagler, Arnon
    CLINICAL CANCER RESEARCH, 2008, 14 (10) : 3044 - 3051
  • [10] Selinexor Enhances Natural Killer Cell Function Against Multiple Myeloma Cells
    Fisher, Jack G.
    Doyle, Amber D. P.
    Graham, Lara V.
    Forconi, Francesco
    Cragg, Mark S.
    Walker, Christopher J.
    Khakoo, Salim I.
    Blunt, Matthew D.
    BLOOD, 2023, 142
12345